Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 2, 1997, Pages 169-175

  Gaumond, Fanny ^a   Fortin, Denis ^a   Stankova, Jana ^a   Rola Pleszczynski, Marek ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

G proteins; PAF; Phospholipase A2 cAMP; Tyrosine kinase

Indexed keywords

BUCLADESINE; CYCLIC AMP; ERBSTATIN; FORSKOLIN; GENISTEIN; INDOMETACIN; INTERLEUKIN 6; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NIFEDIPINE; PERTUSSIS TOXIN; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; INDICATORS AND REAGENTS; INTERLEUKIN-6; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PROTEIN-TYROSINE KINASES; RATS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0030732711     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199708000-00004     Document Type: Article

References (52)

1. Evangelou AM. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukot Essent Fatty Acids 1994;50:1-28.
2. Tomlinson PR, Croft K, Harris T, Stewart AG. Platelet-activating factor biosynthesis in rat vascular smooth muscle cells. J Vasc Res 1994;31:144-52.
3. Brock TA, Gimbrone MA. Platelet activating factor alters calcium homeostasis in cultured vascular endothelial cells. Am J Physiol 1986;250:H1086-92.
4. Doyle VM, Creba JA, Ruegg UT. Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. FEBS Lett 1986;197:13-6.
5. Kawaguchi H, Yasuda H. Effects of platelet-activating factor on conversion of angiotensin I to II. FEBS Lett 1987;221:305-8.
6. D'Humières SD, Russo-Marie F, Vargaftig BB. PAF-acether-induced synthesis of prostacyclin by human endothelial cells. Eur J Pharmacol 1986;131:13-9.
7. Kawaguchi H, Yasuda H. Platelet-activating factor stimulates prostaglandin synthesis in cultured cells. Hypertension 1986;8:192-7.
8. 2 biosynthesis in rat vascular smooth muscle cells. Biochem Pharmacol 1990;40:2713-7.
9. 4 and PAF: transcriptional and post-transcriptional regulation. In: Martyn Bailey J, ed. Prostaglandins, leukotrienes, lipoxins and PAF. New York: Plenum Press, 1991:329-34.
10. Bauer J, Ganter U, Geiger T, et al. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 1988;72:1134-40.
11. 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci U S A 1988;85:6701-5.
12. 2 (BSF-2, IL-6). Science 1988;239:502-4.
13. Van Damme J, Van Beeumen J, Decock B, et al. Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1β and hybridoma growth factor (HGF): identification of leukocyte-derived HGF as IL-6. J Immunol 1988;140:1534-41.
14. Navarro S, Debili N, Bernaudin JF, Vainchenker W, Doly J. Regulation of the expression of IL-6 in human monocytes. J Immunol 1989;142:4339-45.
15. Content J, De Wit L, Pierard D, Derynck R, De Clercq E, Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon β. Proc Natl Acad Sci U S A 1982;79:2768-72.
16. Wolvekamp MCJ, Marquet RL. Interleukin-6: historical background, genetics and biological significance. Immunol Lett 1990;24:1-10.
17. Jirik FR, Podor TJ, Hirano T, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144-7.
18. Shalaby MR, Waage A. and Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 1989;121:372-82.
19. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989;142:549-53.
20. Loppnow H, Libby P. Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL-1. Cell Immunol 1989;122:493-503.
21. Holzinger C, Weissinger E, Zuckermann A, et al. Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. Immunol Lett 1993;35:109-18.
22. Loppnow H, Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990;85:731-8.
23. Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int 1990;20:445-54.
24. Ikeda U, Ikeda M, Oohara T. et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in PDGF-dependent manner. Am J Physiol 1991;260:H1713-7.
25. Lansdorp PM, Aarden LA, Calafat J, Zeiljemaker WP. A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986;132:105-11.
26. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-6.
27. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-β2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988;263:6177-82.
28. Saltis J, Agrotis A, Bobik A. TGF-β1, potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol 1992;263:C420-8.
29. Ikeda U, Ikeda M, Oohara T, Kano S, Yaginuma T. Mitogenic action of interleukin-1a on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 1990;84:183-8.
30. Morimoto S, Nabata T, Koh E, et al. Interleukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1β. J Cardiovasc Pharmacol 1991;17:S117-8.
31. Stoll LL, Spector AA. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture. J Cell Physiol 1989;139:253-61.
32. Zeng GQ, Ju DW, Sun DX, Rui YC. Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture. Acta Pharmacol Sin 1993;14:329-31.
33. 4 enhances interleukin-6 (IL-6) messenger RNA accumulation in human monocytes in vitro: transcriptional and post-transcriptional mechanisms. Blood 1992;80:1004-11.
34. Thivierge M, Rola-Pleszczynski M. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J Allergy Clin Immunol 1992;90:796-802.
35. 2. J Lipid Med 1993;6:175-81.
36. Mori M, Bito H, Sakanaka C, et al. Activation of mitogen-activated protein kinase and arachidonate release via two G protein-coupled receptors expressed in the rat hippocampus. Ann N Y Acad Sci 1994;744:107-25.
37. Naccache PM, Molski MM, Volpi M, Becker EL, Sha'afi RI. Unique inhibitory profile of PAF induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils toward pertussis toxin and phorbol ester. Biochem Biophys Res Commun 1985;130:677-84.
38. Huang SJ, Monk PN, Downes CP, Whetton AD. Platelet-activating factor induced hydrolysis of phosphatidylinositol-4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. Biochem J 1988;249:839-45.
39. Barzaghi G, Saran HM, Mong S. Platelet activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. J Pharmacol Exp Ther 1989;248:559-66.
40. Dhar A, Paul A, Shukla SD. Involvement of tyrosine kinase in PAF stimulation of phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody of phosphotyrosine. Mol Pharmacol 1990;37:519-25.
41. Thurston AW, Shukla SD. Dual mechanisms for phospholipase C activation by platelet activating factor receptor involving G-proteins and tyrosine kinase in A431 cells. FASEB J 1992;6: A1921.
42. q pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation. J Biol Chem 1995;270:4840-4.
43. Mazer BD, Sawami H, Tordai A, Gelfand EW. Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway. J Clin Invest 1992;90:759-65.
44. Xuang YT, Su YF, Chang KJ, Watkins WD. A pertussis/cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell. Biochem Biophys Res Commun 1987;146:898-906.
45. 1 on DNA synthesis in vascular smooth muscle cells. Am J Physiol 1986;250:C584-8.
46. 2 in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1988; 71:165-71.
47. Shimizu T, Honda Z, Naramura M, Sito H, Izumi T. Platelet-activating factor receptor and signal transduction. Biochem Pharmacol 1992;44:1001-8.
48. Shukla SD. Platelet activating factor receptor and signal transduction mechanisms. FASEB J 1992;6:2296-301.
49. Kuruvilla A, Putcha G, Poulos E, Shearer WT. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in human B cell line. J Immunol 1993; 151:637-48.
50. Thurston AW, Sue Goo Rhee S, Shukla SD. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms. J Pharmacol Exp Ther 1993;266:1106-12.
51. Shukla SD. Inositol phospholipid turnover in PAF transmembrane signalling. Lipids 1991;26:1028-33.
52. Porreca E, Di Febbo C, Reale M, et al. Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1. Atherosclerosis 1995; 113:11-8.